Kraft Heinz Reports Third Quarter 2024 Results
Narrows Full Year Outlook for Organic
Third Quarter Highlights
-
Net sales decreased 2.8%; Organic
Net Sales (1) decreased 2.2%
- Gross profit margin increased 20 basis points to 34.2%; Adjusted Gross Profit Margin(1) increased 30 basis points to 34.3%
-
Operating income decreased 115.5%, driven by non-cash impairment losses of
$1.4 billion ; Adjusted Operating Income(1) increased 1.4%
-
Diluted EPS was
$(0.24) , down 214.3%; Adjusted EPS(1) was$0.75 , up 4.2%
-
Year-to-date net cash provided by operating activities was
$2.8 billion , up 6.7%; Free Cash Flow(1) was$2.0 billion , up 9.7%
-
Year-to-date return of capital to stockholders was
$2.0 billion
“In the third quarter, our top-line performance across two of our strategic pillars, Global Away From Home and Emerging Markets, grew in line with our expectations,” said
“We continue to make investments in marketing, research and development, and technology as we look to bring solutions to the table that both create value for our consumers and support future top-line growth. We are supporting these investments by our proven ability to sustainably unlock efficiencies and generate strong cash flow.”
Abrams-Rivera continued, “While a recovery is taking longer than originally anticipated, we are not losing sight of our long-term strategy. We remain confident in our ability to drive profitable growth, generate strong cash flow, and return capital to our stockholders.”
|
||||||||||||||
In millions |
||||||||||||||
|
|
|
|
Organic |
||||||||||
|
|
|
|
|
|
% Chg vs
|
|
YoY Growth
|
|
Price |
|
Volume/
|
||
For the Three Months Ended |
|
|
|
|
|
|
|
|
|
|||||
|
|
$ |
4,826 |
|
$ |
4,995 |
|
(3.4)% |
|
(3.2)% |
|
1.2 pp |
|
(4.4) pp |
International Developed Markets |
|
|
882 |
|
|
883 |
|
(0.2)% |
|
(1.8)% |
|
(1.0) pp |
|
(0.8) pp |
Emerging Markets(a) |
|
|
675 |
|
|
692 |
|
(2.4)% |
|
4.9% |
|
3.8 pp |
|
1.1 pp |
|
|
$ |
6,383 |
|
$ |
6,570 |
|
(2.8)% |
|
(2.2)% |
|
1.2 pp |
|
(3.4) pp |
|
||||||||||||||
In millions |
||||||||||||||
|
|
|
|
Organic |
||||||||||
|
|
|
|
|
|
% Chg vs
|
|
YoY Growth
|
|
Price |
|
Volume/
|
||
For the Nine Months Ended |
|
|
|
|
|
|
|
|
|
|||||
|
|
$ |
14,575 |
|
$ |
14,959 |
|
(2.6)% |
|
(2.5)% |
|
1.6 pp |
|
(4.1) pp |
International Developed Markets |
|
|
2,622 |
|
|
2,675 |
|
(2.0)% |
|
(2.4)% |
|
(0.1) pp |
|
(2.3) pp |
Emerging Markets(a) |
|
|
2,073 |
|
|
2,146 |
|
(3.4)% |
|
4.6% |
|
3.3 pp |
|
1.3 pp |
|
|
$ |
19,270 |
|
$ |
19,780 |
|
(2.6)% |
|
(1.7)% |
|
1.6 pp |
|
(3.3) pp |
(a) |
Emerging Markets represents the aggregation of our West and East Emerging Markets (“WEEM”) and Asia Emerging Markets (“AEM”) operating segments. |
||
Net Income/(Loss) and Diluted EPS |
||||||||||||||||
In millions, except per share data |
||||||||||||||||
|
|
For the Three Months Ended |
|
For the Nine Months Ended |
||||||||||||
|
|
|
|
|
|
% Chg vs
|
|
|
|
|
|
% Chg vs
|
||||
Gross profit |
|
$ |
2,186 |
|
$ |
2,235 |
|
(2.2)% |
|
$ |
6,723 |
|
$ |
6,609 |
|
1.7% |
Operating income/(loss) |
|
|
(101) |
|
|
653 |
|
(115.5)% |
|
|
1,723 |
|
|
3,272 |
|
(47.3)% |
Net income/(loss) |
|
|
(290) |
|
|
254 |
|
(214.2)% |
|
|
614 |
|
|
2,089 |
|
(70.6)% |
Net income/(loss) attributable to common shareholders |
|
|
(290) |
|
|
262 |
|
(210.7)% |
|
|
613 |
|
|
2,098 |
|
(70.8)% |
Diluted EPS |
|
$ |
(0.24) |
|
$ |
0.21 |
|
(214.3)% |
|
$ |
0.50 |
|
$ |
1.70 |
|
(70.6)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted EPS(1) |
|
|
0.75 |
|
|
0.72 |
|
4.2% |
|
|
2.22 |
|
|
2.20 |
|
0.9% |
Adjusted Operating Income(1) |
|
$ |
1,330 |
|
$ |
1,312 |
|
1.4% |
|
$ |
3,975 |
|
$ |
3,908 |
|
1.7% |
Q3 2024 Financial Summary
-
Net sales decreased 2.8 percent versus the year-ago period to
$6.4 billion , including a negative 0.4 percentage point impact from foreign currency and a negative 0.2 percentage point impact from divestitures. OrganicNet Sales (1) decreased 2.2 percent versus the prior year period. Price increased 1.2 percentage points versus the prior year period, with increases in theNorth America and Emerging Markets segments partially offset by lower price in International Developed Markets. Favorable price was primarily due to pricing taken in certain categories to mitigate higher input costs. Volume/mix declined 3.4 percentage points versus the prior year period, with declines in theNorth America and International Developed Markets segments partially offset by volume/mix growth in Emerging Markets. Unfavorable volume/mix was primarily driven by continued shifts in consumer behavior due to economic uncertainty and a decline in Lunchables.
-
Operating Income decreased 115.5 percent versus the year-ago period to
$(0.1) billion , as a result of non-cash impairment losses of$1.4 billion in the current year period. This impairment charge was due to an intangible asset impairment largely on the Lunchables brand and a goodwill impairment related to the Continental Europe reporting unit. Excluding the impact of these non-cash impairment losses, operating income increased$12 million due to factors noted in Adjusted Operating Income. Adjusted Operating Income(1) increased 1.4 percent versus the year-ago period to$1.3 billion , primarily driven by higher pricing, the beneficial impact from our efficiency initiatives mostly in procurement, and lower variable compensation expense. These factors more than offset unfavorable volume/mix, increased manufacturing expenses due in part to increased labor costs, and an unfavorable impact from foreign currency (0.2 pp).
-
Diluted EPS decreased 214.3 percent versus the prior year period to
$(0.24) , driven by non-cash impairment losses in the current year period. Adjusted EPS(1) was$0.75 , up 4.2 percent versus the prior year period, primarily driven by higher Adjusted Operating Income, fewer shares outstanding, and lower taxes on adjusted earnings.
-
Year-to-date net cash provided by/(used for) operating activities was
$2.8 billion , up 6.7 percent versus the year-ago period. This increase was primarily due to favorable changes in working capital driven by accounts payable and the lapping of prior year cash payments associated with the settlement of the consolidated securities class action lawsuit, which were partially offset by higher cash outflows from inventory and variable compensation in the 2024 period compared to the 2023 period. Further, net cash by operating activities was favorably impacted by increased Adjusted Operating Income. Free Cash Flow(1) was$2.0 billion , up 9.7 percent versus the prior year period, driven by the same net cash provided by/(used for) operating activities discussed above.
-
Capital Return: Year to date, the Company paid
$1.5 billion in cash dividends and repurchased$538 million of common stock. Of the$538 million in share repurchases in 2024,$350 million were repurchased under the Company’s publicly announced share repurchase program and$188 million were purchased to offset the dilutive effect of equity-based compensation. As ofSept. 28, 2024 , the Company had remaining authorization to repurchase approximately$2.4 billion of common stock under the publicly announced share repurchase program.
Outlook
For fiscal year 2024, the Company now expects:
-
Organic
Net Sales (2) to be at the low end of the previous guidance range of down 2 percent to flat versus the prior year.
- Adjusted Operating Income(2) growth to be at the low end of the previous guidance range of 1 to 3 percent versus the prior year. This also contemplates expected Adjusted Gross Profit Margin(1)(2) expansion at the lower end of the previous range of 75 to 125 basis points versus the prior year.
-
Adjusted EPS(2) growth to be at the low end of the previous guidance range of 1 to 3 percent, or in the range of
$3.01 to$3.07 . The Company expects an effective tax rate on Adjusted EPS to be approximately 21 percent. Additionally, the Company expects interest expense and other expense/(income) to be relatively flat versus the prior year. This guidance does not reflect any impact from future potential share repurchases.
End Notes
(1) |
Organic |
|
(2) |
Guidance for Organic |
Earnings Discussion and Webcast Information
A pre-recorded management discussion of
ABOUT
We are driving transformation at
Forward-Looking Statements
This press release contains a number of forward-looking statements. Words such as “accelerate,” “anticipate,” “believe,” “commit,” “continue,” “expect,” “will,” “guidance,” and “outlook,” and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements regarding the Company's plans, impacts of accounting standards and guidance, growth, legal matters, taxes, costs and cost savings, impairments, dividends, expectations, investments, innovations, opportunities, capabilities, execution, initiatives, and pipeline. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond the Company's control.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, operating in a highly competitive industry; the Company’s ability to correctly predict, identify, and interpret changes in consumer preferences and demand, to offer new products to meet those changes, and to respond to competitive innovation; changes in the retail landscape or the loss of key retail customers; changes in the Company's relationships with significant customers or suppliers, or in other business relationships; the Company’s ability to maintain, extend, and expand its reputation and brand image; the Company’s ability to leverage its brand value to compete against private label products; the Company’s ability to drive revenue growth in its key product categories or platforms, increase its market share, or add products that are in faster-growing and more profitable categories; product recalls or other product liability claims; climate change and legal or regulatory responses; the Company’s ability to identify, complete, or realize the benefits from strategic acquisitions, divestitures, alliances, joint ventures, or investments; the Company's ability to successfully execute its strategic initiatives; the impacts of the Company's international operations; the Company's ability to protect intellectual property rights; the Company’s ability to realize the anticipated benefits from prior or future streamlining actions to reduce fixed costs, simplify or improve processes, and improve its competitiveness; the influence of the Company's largest stockholder; the Company's level of indebtedness, as well as our ability to comply with covenants under our debt instruments; additional impairments of the carrying amounts of goodwill or other indefinite-lived intangible assets; foreign exchange rate fluctuations; volatility in commodity, energy, and other input costs; volatility in the market value of all or a portion of the commodity derivatives we use; compliance with laws and regulations and related legal claims or regulatory enforcement actions; failure to maintain an effective system of internal controls; a downgrade in the Company's credit rating; the impact of sales of the Company's common stock in the public market; the impact of the Company’s share repurchases or any change in the Company’s share repurchase activity; the Company’s ability to continue to pay a regular dividend and the amounts of any such dividends; disruptions in the global economy caused by geopolitical conflicts, unanticipated business disruptions and natural events in the locations in which the Company or the Company's customers, suppliers, distributors, or regulators operate; economic and political conditions in
We use our investor relations website, ir.kraftheinzcompany.com, as a routine channel for distribution of important, and often material, information about
Non-GAAP Financial Measures
The non-GAAP financial measures provided in this press release should be viewed in addition to, and not as an alternative for, results prepared in accordance with accounting principles generally accepted in
To supplement the financial information provided, the Company has presented Organic
Management uses these non-GAAP financial measures to assist in comparing the Company’s performance on a consistent basis for purposes of business decision making by removing the impact of certain items that management believes do not directly reflect the Company’s underlying operations. The Company believes:
-
Organic
Net Sales , Adjusted Operating Income, Constant Currency Adjusted Operating Income, Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted Net Income/(Loss), and Adjusted EPS provide important comparability of underlying operating results, allowing investors and management to assess the Company’s operating performance on a consistent basis; and
- Free Cash Flow and Net Leverage provide measures of the Company’s core operating performance, the cash-generating capabilities of the Company’s business operations, and are factors used in determining the Company’s borrowing capacity and the amount of cash available for debt repayments, dividends, acquisitions, share repurchases, and other corporate purposes.
Management believes that presenting the Company’s non-GAAP financial measures is useful to investors because it (i) provides investors with meaningful supplemental information regarding financial performance by excluding certain items, (ii) permits investors to view performance using the same tools that management uses to budget, make operating and strategic decisions, and evaluate historical performance, and (iii) otherwise provides supplemental information that may be useful to investors in evaluating the Company’s results. The Company believes that the presentation of these non-GAAP financial measures, when considered together with the corresponding GAAP financial measures and the reconciliations to those measures, provides investors with additional understanding of the factors and trends affecting the Company’s business than could be obtained absent these disclosures.
Definitions
Organic
Adjusted Operating Income is defined as operating income/(loss) excluding, when they occur, the impacts of restructuring activities, deal costs, unrealized gains/(losses) on commodity hedges (the unrealized gains and losses are recorded in general corporate expenses until realized; once realized, the gains and losses are recorded in the applicable segment’s operating results), impairment losses, and certain non-ordinary course legal and regulatory matters. The Company also presents Adjusted Operating Income on a constant currency basis (Constant Currency Adjusted Operating Income). The Company calculates the impact of currency on Adjusted Operating Income by holding exchange rates constant at the previous year's exchange rate, with the exception of highly inflationary subsidiaries, for which it calculates the previous year's results using the current year's exchange rate.
Adjusted Gross Profit, Adjusted Net Income/(Loss), and Adjusted EPS
are defined as gross profit, net income/(loss), and diluted earnings per share, respectively, excluding, when they occur, the impacts of restructuring activities, deal costs, unrealized losses/(gains) on commodity hedges, impairment losses, certain non-ordinary course legal and regulatory matters, losses/(gains) on the sale of a business, other losses/(gains) related to acquisitions and divestitures (e.g., tax and hedging impacts), nonmonetary currency devaluation (e.g., remeasurement gains and losses), debt prepayment and extinguishment (benefit)/costs, and certain significant discrete income tax items (e.g.,
Net Leverage is defined as debt less cash, cash equivalents and short-term investments divided by Adjusted EBITDA. Adjusted EBITDA is defined as net income/(loss) from continuing operations before interest expense, other expense/(income), provision for/(benefit from) income taxes, and depreciation and amortization (excluding restructuring activities); in addition to these adjustments, the Company excludes, when they occur, the impacts of divestiture-related license income, restructuring activities, deal costs, unrealized losses/(gains) on commodity hedges, impairment losses, certain non-ordinary course legal and regulatory matters, and equity award compensation expense (excluding restructuring activities).
Free Cash Flow is defined as net cash provided by/(used for) operating activities less capital expenditures. The use of this non-GAAP measure does not imply or represent the residual cash flow for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure.
Schedule 1 |
|||||||||||
Condensed Consolidated Statements of Income (in millions, except per share data) (Unaudited) |
|||||||||||
|
For the Three Months Ended |
|
For the Nine Months Ended |
||||||||
|
|
|
|
|
|
|
|
||||
Net sales |
$ |
6,383 |
|
$ |
6,570 |
|
$ |
19,270 |
|
$ |
19,780 |
Cost of products sold |
|
4,197 |
|
|
4,335 |
|
|
12,547 |
|
|
13,171 |
Gross profit |
|
2,186 |
|
|
2,235 |
|
|
6,723 |
|
|
6,609 |
Selling, general and administrative expenses, excluding impairment losses |
|
859 |
|
|
920 |
|
|
2,718 |
|
|
2,675 |
|
|
707 |
|
|
510 |
|
|
1,561 |
|
|
510 |
Intangible asset impairment losses |
|
721 |
|
|
152 |
|
|
721 |
|
|
152 |
Selling, general and administrative expenses |
|
2,287 |
|
|
1,582 |
|
|
5,000 |
|
|
3,337 |
Operating income/(loss) |
|
(101) |
|
|
653 |
|
|
1,723 |
|
|
3,272 |
Interest expense |
|
230 |
|
|
228 |
|
|
685 |
|
|
683 |
Other expense/(income) |
|
(48) |
|
|
(35) |
|
|
(56) |
|
|
(94) |
Income/(loss) before income taxes |
|
(283) |
|
|
460 |
|
|
1,094 |
|
|
2,683 |
Provision for/(benefit from) income taxes |
|
7 |
|
|
206 |
|
|
480 |
|
|
594 |
Net income/(loss) |
|
(290) |
|
|
254 |
|
|
614 |
|
|
2,089 |
Net income/(loss) attributable to noncontrolling interest |
|
— |
|
|
(8) |
|
|
1 |
|
|
(9) |
Net income/(loss) attributable to common shareholders |
$ |
(290) |
|
$ |
262 |
|
$ |
613 |
|
$ |
2,098 |
|
|
|
|
|
|
|
|
||||
Basic shares outstanding |
|
1,210 |
|
|
1,229 |
|
|
1,212 |
|
|
1,228 |
Diluted shares outstanding |
|
1,210 |
|
|
1,235 |
|
|
1,217 |
|
|
1,235 |
|
|
|
|
|
|
|
|
||||
Per share data applicable to common shareholders: |
|
|
|
|
|
|
|
||||
Basic earnings/(loss) per share |
$ |
(0.24) |
|
$ |
0.21 |
|
$ |
0.51 |
|
$ |
1.71 |
Diluted earnings/(loss) per share |
|
(0.24) |
|
|
0.21 |
|
|
0.50 |
|
|
1.70 |
|
|
|
|
|
|
|
|
||||||||
Schedule 2 |
|||||||||||||||
Reconciliation of For the Three Months Ended (dollars in millions) (Unaudited) |
|||||||||||||||
|
|
|
Currency |
|
Acquisitions
|
|
Organic Net
|
|
Price |
|
Volume/Mix |
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
$ |
4,826 |
|
$ |
(8) |
|
$ |
— |
|
$ |
4,834 |
|
|
|
|
International Developed Markets |
|
882 |
|
|
15 |
|
|
— |
|
|
867 |
|
|
|
|
Emerging Markets |
|
675 |
|
|
(23) |
|
|
— |
|
|
698 |
|
|
|
|
|
$ |
6,383 |
|
$ |
(16) |
|
$ |
— |
|
$ |
6,399 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
$ |
4,995 |
|
$ |
— |
|
$ |
— |
|
$ |
4,995 |
|
|
|
|
International Developed Markets |
|
883 |
|
|
— |
|
|
— |
|
|
883 |
|
|
|
|
Emerging Markets |
|
692 |
|
|
11 |
|
|
16 |
|
|
665 |
|
|
|
|
|
$ |
6,570 |
|
$ |
11 |
|
$ |
16 |
|
$ |
6,543 |
|
|
|
|
Year-over-year growth rates |
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
(3.4)% |
|
(0.2) pp |
|
0.0 pp |
|
|
(3.2)% |
|
1.2 pp |
|
(4.4) pp |
||
International Developed Markets |
|
(0.2)% |
|
1.6 pp |
|
0.0 pp |
|
|
(1.8)% |
|
(1.0) pp |
|
(0.8) pp |
||
Emerging Markets |
|
(2.4)% |
|
(4.9) pp |
|
(2.4) pp |
|
|
4.9% |
|
3.8 pp |
|
1.1 pp |
||
|
|
(2.8)% |
|
(0.4) pp |
|
(0.2) pp |
|
|
(2.2)% |
|
1.2 pp |
|
(3.4) pp |
|
|
|
|
|
|
|
|
||||||||
Schedule 3 |
|||||||||||||||
Reconciliation of For the Nine Months Ended (dollars in millions) (Unaudited) |
|||||||||||||||
|
|
|
Currency |
|
Acquisitions
|
|
Organic Net
|
|
Price |
|
Volume/Mix |
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
$ |
14,575 |
|
$ |
(15) |
|
$ |
— |
|
$ |
14,590 |
|
|
|
|
International Developed Markets |
|
2,622 |
|
|
10 |
|
|
— |
|
|
2,612 |
|
|
|
|
Emerging Markets(a) |
$ |
2,073 |
|
$ |
(69) |
|
$ |
12 |
|
$ |
2,130 |
|
|
|
|
|
$ |
19,270 |
|
$ |
(74) |
|
$ |
12 |
|
$ |
19,332 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
$ |
14,959 |
|
$ |
— |
|
$ |
— |
|
$ |
14,959 |
|
|
|
|
International Developed Markets |
|
2,675 |
|
|
— |
|
|
— |
|
|
2,675 |
|
|
|
|
Emerging Markets(a) |
$ |
2,146 |
|
$ |
59 |
|
$ |
50 |
|
$ |
2,037 |
|
|
|
|
|
$ |
19,780 |
|
$ |
59 |
|
$ |
50 |
|
$ |
19,671 |
|
|
|
|
Year-over-year growth rates |
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
(2.6)% |
|
(0.1) pp |
|
0.0 pp |
|
|
(2.5)% |
|
1.6 pp |
|
(4.1) pp |
||
International Developed Markets |
|
(2.0)% |
|
0.4 pp |
|
0.0 pp |
|
|
(2.4)% |
|
(0.1) pp |
|
(2.3) pp |
||
Emerging Markets(a) |
|
(3.4)% |
|
(6.1) pp |
|
(1.9) pp |
|
|
4.6% |
|
3.3 pp |
|
1.3 pp |
||
|
|
(2.6)% |
|
(0.7) pp |
|
(0.2) pp |
|
|
(1.7)% |
|
1.6 pp |
|
(3.3) pp |
(a) |
Emerging Markets represents the aggregation of our WEEM and AEM operating segments. |
|
|
|
|
|
||||||||
Schedule 4 |
|||||||||||
Reconciliation of Operating Income/(Loss) to Adjusted Operating Income (dollars in millions) (Unaudited) |
|||||||||||
|
For the Three Months Ended |
|
For the Nine Months Ended |
||||||||
|
|
|
|
|
|
|
|
||||
Operating income/(loss) |
$ |
(101) |
|
$ |
653 |
|
|
1,723 |
|
|
3,272 |
Restructuring activities |
|
— |
|
|
45 |
|
|
— |
|
|
25 |
Unrealized losses/(gains) on commodity hedges |
|
3 |
|
|
(48) |
|
|
(30) |
|
|
(53) |
Impairment losses |
|
1,428 |
|
|
662 |
|
|
2,282 |
|
|
662 |
Certain non-ordinary course legal and regulatory matters |
|
— |
|
|
— |
|
|
— |
|
|
2 |
Adjusted Operating Income |
$ |
1,330 |
|
$ |
1,312 |
|
$ |
3,975 |
|
$ |
3,908 |
|
|
|
|
|
|
|
|
||||
Segment Adjusted Operating Income: |
|
|
|
|
|
|
|
||||
|
$ |
1,237 |
|
$ |
1,245 |
|
$ |
3,793 |
|
$ |
3,701 |
International Developed Markets |
|
135 |
|
|
129 |
|
|
397 |
|
|
376 |
Total Segment Adjusted Operating Income |
|
1,372 |
|
|
1,374 |
|
|
4,190 |
|
|
4,077 |
Emerging Markets Segment Adjusted Operating Income(a) |
|
84 |
|
|
88 |
|
|
232 |
|
|
286 |
General corporate expenses |
|
(126) |
|
|
(150) |
|
|
(447) |
|
|
(455) |
Adjusted Operating Income |
$ |
1,330 |
|
$ |
1,312 |
|
$ |
3,975 |
|
$ |
3,908 |
(a) |
Segment Adjusted Operating Income for Emerging Markets, which represents the combination of our WEEM and AEM operating segments, is defined and presented consistently with the Segment Adjusted Operating Income of our reportable segments - |
|
|
|
|
|
|||||
Schedule 5 |
||||||||
Reconciliation of Adjusted Operating Income to Constant Currency Adjusted Operating Income For the Three Months Ended (dollars in millions) (Unaudited) |
||||||||
|
Adjusted Operating
|
|
Currency |
|
Constant Currency
|
|||
|
|
|
|
|
|
|||
|
$ |
1,237 |
|
$ |
(3) |
|
$ |
1,240 |
International Developed Markets |
|
135 |
|
|
3 |
|
|
132 |
Emerging Markets |
|
84 |
|
|
(1) |
|
|
85 |
General corporate expenses |
|
(126) |
|
|
— |
|
|
(126) |
|
$ |
1,330 |
|
$ |
(1) |
|
$ |
1,331 |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
$ |
1,245 |
|
$ |
— |
|
$ |
1,245 |
International Developed Markets |
|
129 |
|
|
— |
|
|
129 |
Emerging Markets |
|
88 |
|
|
2 |
|
|
86 |
General corporate expenses |
|
(150) |
|
|
— |
|
|
(150) |
|
$ |
1,312 |
|
$ |
2 |
|
$ |
1,310 |
Year-over-year growth rates |
|
|
|
|
|
|||
|
|
(0.6)% |
|
(0.2) pp |
|
|
(0.4)% |
|
International Developed Markets |
|
4.2% |
|
2.2 pp |
|
|
2.0% |
|
Emerging Markets |
|
(4.5)% |
|
(3.5) pp |
|
|
(1.0)% |
|
General corporate expenses |
|
(15.9)% |
|
0.3 pp |
|
|
(16.2)% |
|
|
|
1.4% |
|
(0.2) pp |
|
|
1.6% |
|
|
|
|
|||||
Schedule 6 |
||||||||
Reconciliation of Adjusted Operating Income to Constant Currency Adjusted Operating Income For the Nine Months Ended (dollars in millions) (Unaudited) |
||||||||
|
Adjusted Operating Income |
|
Currency |
|
Constant Currency Adjusted Operating Income |
|||
|
|
|
|
|
|
|||
|
$ |
3,793 |
|
$ |
(4) |
|
$ |
3,797 |
International Developed Markets |
|
397 |
|
|
7 |
|
|
390 |
Emerging Markets |
|
232 |
|
|
(9) |
|
|
241 |
General corporate expenses |
|
(447) |
|
|
(1) |
|
|
(446) |
|
$ |
3,975 |
|
$ |
(7) |
|
$ |
3,982 |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
$ |
3,701 |
|
$ |
— |
|
$ |
3,701 |
International Developed Markets |
|
376 |
|
|
— |
|
|
376 |
Emerging Markets |
|
286 |
|
|
11 |
|
|
275 |
General corporate expenses |
|
(455) |
|
|
— |
|
|
(455) |
|
$ |
3,908 |
|
$ |
11 |
|
$ |
3,897 |
Year-over-year growth rates |
|
|
|
|
|
|||
|
|
2.5% |
|
(0.1) pp |
|
|
2.6% |
|
International |
|
5.6% |
|
1.7 pp |
|
|
3.9% |
|
Emerging Markets |
|
(19.0)% |
|
(6.5) pp |
|
|
(12.5)% |
|
General corporate expenses |
|
(1.8)% |
|
0.3 pp |
|
|
(2.1)% |
|
|
|
1.7% |
|
(0.5) pp |
|
|
2.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Schedule 7 |
||||||||||||||||||||||||||||||||
Reconciliation of GAAP Results to Non-GAAP Results (dollars in millions) (Unaudited) |
||||||||||||||||||||||||||||||||
|
For the Three Months Ended |
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
Gross
|
|
Selling,
|
|
Operating
|
|
Interest
|
|
Other
|
|
Income/
|
|
Provision
|
|
Net
|
|
Net
|
|
Net
|
|
Diluted
|
|||||||||||
GAAP Results |
$ |
2,186 |
|
$ |
2,287 |
|
$ |
(101) |
|
$ |
230 |
|
$ |
(48) |
|
$ |
(283) |
|
$ |
7 |
|
$ |
(290) |
|
$ |
— |
|
$ |
(290) |
|
$ |
(0.24) |
Items Affecting Comparability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring activities |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
7 |
|
|
(7) |
|
|
(2) |
|
|
(5) |
|
|
— |
|
|
(5) |
|
|
— |
Unrealized losses/(gains) on commodity hedges |
|
3 |
|
|
— |
|
|
3 |
|
|
— |
|
|
— |
|
|
3 |
|
|
1 |
|
|
2 |
|
|
— |
|
|
2 |
|
|
— |
Impairment losses |
|
— |
|
|
(1,428) |
|
|
1,428 |
|
|
— |
|
|
— |
|
|
1,428 |
|
|
229 |
|
|
1,199 |
|
|
— |
|
|
1,199 |
|
|
0.99 |
Losses/(gains) on sale of business |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(4) |
|
|
4 |
|
|
— |
|
|
4 |
|
|
— |
Nonmonetary currency devaluation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(3) |
|
|
3 |
|
|
— |
|
|
3 |
|
|
— |
|
|
3 |
|
|
— |
Adjusted Non-GAAP Results |
$ |
2,189 |
|
|
|
$ |
1,330 |
|
|
|
|
|
|
|
|
|
$ |
913 |
|
|
|
|
|
$ |
0.75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Schedule 8 |
||||||||||||||||||||||||||||||||
Reconciliation of GAAP Results to Non-GAAP Results (dollars in millions) (Unaudited) |
||||||||||||||||||||||||||||||||
|
For the Three Months Ended |
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
Gross
|
|
Selling,
|
|
Operating
|
|
Interest
|
|
Other
|
|
Income/
|
|
Provision
|
|
Net
|
|
Net
|
|
Net
|
|
Diluted
|
|||||||||||
GAAP Results |
$ |
2,235 |
|
$ |
1,582 |
|
$ |
653 |
|
$ |
228 |
|
$ |
(35) |
|
$ |
460 |
|
$ |
206 |
|
$ |
254 |
|
$ |
(8) |
|
$ |
262 |
|
$ |
0.21 |
Items Affecting Comparability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring activities |
|
44 |
|
|
(1) |
|
|
45 |
|
|
— |
|
|
— |
|
|
45 |
|
|
8 |
|
|
37 |
|
|
— |
|
|
37 |
|
|
0.03 |
Unrealized losses/(gains) on commodity hedges |
|
(48) |
|
|
— |
|
|
(48) |
|
|
— |
|
|
— |
|
|
(48) |
|
|
(12) |
|
|
(36) |
|
|
— |
|
|
(36) |
|
|
(0.03) |
Impairment losses |
|
— |
|
|
(662) |
|
|
662 |
|
|
— |
|
|
— |
|
|
662 |
|
|
36 |
|
|
626 |
|
|
6 |
|
|
620 |
|
|
0.50 |
Nonmonetary currency devaluation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(9) |
|
|
9 |
|
|
— |
|
|
9 |
|
|
— |
|
|
9 |
|
|
0.01 |
Adjusted Non-GAAP Results |
$ |
2,231 |
|
|
|
$ |
1,312 |
|
|
|
|
|
|
|
|
|
$ |
890 |
|
|
|
|
|
$ |
0.72 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Schedule 9 |
||||||||||||||||||||||||||||||||
Reconciliation of GAAP Results to Non-GAAP Results (dollars in millions) (Unaudited) |
||||||||||||||||||||||||||||||||
|
For the Nine Months Ended |
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
Gross
|
|
Selling,
|
|
Operating
|
|
Interest
|
|
Other
|
|
Income/
|
|
Provision
|
|
Net
|
|
Net
|
|
Net
|
|
Diluted
|
|||||||||||
GAAP Results |
$ |
6,723 |
|
$ |
5,000 |
|
$ |
1,723 |
|
$ |
685 |
|
$ |
(56) |
|
$ |
1,094 |
|
$ |
480 |
|
$ |
614 |
|
$ |
1 |
|
$ |
613 |
|
$ |
0.50 |
Items Affecting Comparability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring activities |
|
2 |
|
|
2 |
|
|
— |
|
|
— |
|
|
8 |
|
|
(8) |
|
|
(2) |
|
|
(6) |
|
|
— |
|
|
(6) |
|
|
— |
Unrealized losses/(gains) on commodity hedges |
|
(30) |
|
|
— |
|
|
(30) |
|
|
— |
|
|
— |
|
|
(30) |
|
|
(8) |
|
|
(22) |
|
|
— |
|
|
(22) |
|
|
(0.02) |
Impairment losses |
|
— |
|
|
(2,282) |
|
|
2,282 |
|
|
— |
|
|
— |
|
|
2,282 |
|
|
229 |
|
|
2,053 |
|
|
— |
|
|
2,053 |
|
|
1.69 |
Losses/(gains) on sale of business |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(78) |
|
|
78 |
|
|
21 |
|
|
57 |
|
|
— |
|
|
57 |
|
|
0.05 |
Nonmonetary currency devaluation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(7) |
|
|
7 |
|
|
— |
|
|
7 |
|
|
— |
|
|
7 |
|
|
— |
Adjusted Non-GAAP Results |
$ |
6,695 |
|
|
|
$ |
3,975 |
|
|
|
|
|
|
|
|
|
$ |
2,703 |
|
|
|
|
|
$ |
2.22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Schedule 10 |
||||||||||||||||||||||||||||||||
Reconciliation of GAAP Results to Non-GAAP Results (dollars in millions) (Unaudited) |
||||||||||||||||||||||||||||||||
|
For the Nine Months Ended |
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
Gross
|
|
Selling,
|
|
Operating
|
|
Interest
|
|
Other
|
|
Income/
|
|
Provision
|
|
Net
|
|
Net
|
|
Net
|
|
Diluted
|
|||||||||||
GAAP Results |
$ |
6,609 |
|
$ |
3,337 |
|
$ |
3,272 |
|
$ |
683 |
|
$ |
(94) |
|
$ |
2,683 |
|
$ |
594 |
|
$ |
2,089 |
|
$ |
(9) |
|
$ |
2,098 |
|
$ |
1.70 |
Items Affecting Comparability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring activities |
|
44 |
|
|
19 |
|
|
25 |
|
|
— |
|
|
(2) |
|
|
27 |
|
|
5 |
|
|
22 |
|
|
— |
|
|
22 |
|
|
0.02 |
Unrealized losses/(gains) on commodity hedges |
|
(53) |
|
|
— |
|
|
(53) |
|
|
— |
|
|
— |
|
|
(53) |
|
|
(13) |
|
|
(40) |
|
|
— |
|
|
(40) |
|
|
(0.03) |
Impairment losses |
|
— |
|
|
(662) |
|
|
662 |
|
|
— |
|
|
— |
|
|
662 |
|
|
36 |
|
|
626 |
|
|
6 |
|
|
620 |
|
|
0.50 |
Certain non-ordinary course legal and regulatory matters |
|
— |
|
|
(2) |
|
|
2 |
|
|
— |
|
|
— |
|
|
2 |
|
|
— |
|
|
2 |
|
|
— |
|
|
2 |
|
|
— |
Losses/(gains) on sale of business |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(2) |
|
|
2 |
|
|
— |
|
|
2 |
|
|
— |
|
|
2 |
|
|
— |
Nonmonetary currency devaluation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(27) |
|
|
27 |
|
|
— |
|
|
27 |
|
|
— |
|
|
27 |
|
|
0.02 |
Certain significant discrete income tax items |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
17 |
|
|
(17) |
|
|
— |
|
|
(17) |
|
|
(0.01) |
Adjusted Non-GAAP Results |
$ |
6,600 |
|
|
|
$ |
3,908 |
|
|
|
|
|
|
|
|
|
$ |
2,711 |
|
|
|
|
|
$ |
2.20 |
|
|
|
|
||||||||
Schedule 11 |
|||||||||||
Adjusted Gross Profit Margin (dollars in millions) (Unaudited) |
|||||||||||
|
For the Three Months Ended |
|
For the Nine Months Ended |
||||||||
|
|
|
|
|
|
|
|
||||
Adjusted Gross Profit |
$ |
2,189 |
|
$ |
2,231 |
|
$ |
6,695 |
|
$ |
6,600 |
Net sales |
|
6,383 |
|
|
6,570 |
|
|
19,270 |
|
|
19,780 |
|
|
|
|
|
|
|
|
||||
Adjusted Gross Profit Margin |
|
34.3% |
|
|
34.0% |
|
|
34.7% |
|
|
33.4% |
|
|
|||||||
Schedule 12 |
||||||||
(Unaudited) |
||||||||
|
For the Three Months Ended |
|
|
|||||
|
|
|
|
|
$ Change |
|||
Key drivers of change in Adjusted EPS: |
|
|
|
|
|
|||
Results of operations(a)(b) |
$ |
0.84 |
|
$ |
0.83 |
|
$ |
0.01 |
Interest expense |
|
(0.15) |
|
|
(0.15) |
|
|
— |
Other expense/(income) |
|
0.04 |
|
|
0.04 |
|
|
— |
Effective tax rate |
|
0.01 |
|
|
— |
|
|
0.01 |
Effect of share repurchases |
|
0.01 |
|
|
— |
|
|
0.01 |
Adjusted EPS |
$ |
0.75 |
|
$ |
0.72 |
|
$ |
0.03 |
(a) |
|
Includes non-cash amortization of definite-lived intangible assets, which accounted for a negative impact to Adjusted EPS from results of operations of |
(b) |
|
Includes divestiture-related license income, which accounted for a benefit to Adjusted EPS from results of operations of |
|
|
|||||||
Schedule 13 |
||||||||
(Unaudited) |
||||||||
|
For the Nine Months Ended |
|
|
|||||
|
|
|
|
|
$ Change |
|||
Key drivers of change in Adjusted EPS: |
|
|
|
|
|
|||
Results of operations(a)(b) |
$ |
2.60 |
|
$ |
2.56 |
|
$ |
0.04 |
Interest expense |
|
(0.45) |
|
|
(0.45) |
|
|
— |
Other expense/(income) |
|
0.09 |
|
|
0.09 |
|
|
— |
Effective tax rate |
|
(0.05) |
|
|
— |
|
|
(0.05) |
Effect of share repurchases |
|
0.03 |
|
|
— |
|
|
0.03 |
Adjusted EPS |
$ |
2.22 |
|
$ |
2.20 |
|
$ |
0.02 |
(a) |
|
Includes non-cash amortization of definite-lived intangible assets, which accounted for a negative impact to Adjusted EPS from results of operations of |
(b) |
|
Includes divestiture-related license income, which accounted for a benefit to Adjusted EPS from results of operations of |
|
|
||||
Schedule 14 |
|||||
Condensed Consolidated Balance Sheets (in millions, except per share data) (Unaudited) |
|||||
|
|
|
|
||
ASSETS |
|
|
|
||
Cash and cash equivalents |
$ |
1,284 |
|
$ |
1,400 |
Trade receivables, net |
|
2,178 |
|
|
2,112 |
Inventories |
|
3,872 |
|
|
3,614 |
Prepaid expenses |
|
228 |
|
|
234 |
Other current assets |
|
633 |
|
|
566 |
Assets held for sale |
|
7 |
|
|
3 |
Total current assets |
|
8,202 |
|
|
7,929 |
Property, plant and equipment, net |
|
7,137 |
|
|
7,122 |
|
|
28,946 |
|
|
30,459 |
Intangible assets, net |
|
41,802 |
|
|
42,448 |
Other non-current assets |
|
2,479 |
|
|
2,381 |
TOTAL ASSETS |
$ |
88,566 |
|
$ |
90,339 |
LIABILITIES AND EQUITY |
|
|
|
||
Commercial paper and other short-term debt |
$ |
13 |
|
$ |
— |
Current portion of long-term debt |
|
695 |
|
|
638 |
Accounts payable |
|
4,553 |
|
|
4,627 |
Accrued marketing |
|
752 |
|
|
733 |
Interest payable |
|
273 |
|
|
258 |
Income taxes payable |
|
— |
|
|
— |
Other current liabilities |
|
1,442 |
|
|
1,781 |
Liabilities held for sale |
|
— |
|
|
— |
Total current liabilities |
|
7,728 |
|
|
8,037 |
Long-term debt |
|
19,383 |
|
|
19,394 |
Deferred income taxes |
|
10,023 |
|
|
10,201 |
Accrued postemployment costs |
|
140 |
|
|
143 |
Long-term deferred income |
|
1,386 |
|
|
1,424 |
Other non-current liabilities |
|
1,437 |
|
|
1,418 |
TOTAL LIABILITIES |
|
40,097 |
|
|
40,617 |
Redeemable noncontrolling interest |
|
6 |
|
|
34 |
Equity: |
|
|
|
||
Common stock, |
|
12 |
|
|
12 |
Additional paid-in capital |
|
52,106 |
|
|
52,037 |
Retained earnings/(deficit) |
|
521 |
|
|
1,367 |
Accumulated other comprehensive income/(losses) |
|
(2,547) |
|
|
(2,604) |
|
|
(1,764) |
|
|
(1,286) |
Total shareholders' equity |
|
48,328 |
|
|
49,526 |
Noncontrolling interest |
|
135 |
|
|
162 |
TOTAL EQUITY |
|
48,463 |
|
|
49,688 |
TOTAL LIABILITIES AND EQUITY |
$ |
88,566 |
|
$ |
90,339 |
|
|
||||
Schedule 15 |
|||||
Condensed Consolidated Statements of Cash Flows (in millions) (Unaudited) |
|||||
|
For the Nine Months Ended |
||||
|
|
|
|
||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
||
Net income/(loss) |
$ |
614 |
|
$ |
2,089 |
Adjustments to reconcile net income/(loss) to operating cash flows: |
|
|
|
||
Depreciation and amortization |
|
714 |
|
|
710 |
Amortization of postemployment benefit plans prior service costs/(credits) |
|
(6) |
|
|
(10) |
Divestiture-related license income |
|
(41) |
|
|
(41) |
Equity award compensation expense |
|
83 |
|
|
110 |
Deferred income tax provision/(benefit) |
|
(277) |
|
|
(15) |
Postemployment benefit plan contributions |
|
16 |
|
|
(18) |
|
|
2,282 |
|
|
662 |
Nonmonetary currency devaluation |
|
7 |
|
|
27 |
Loss/(gain) on sale of business |
|
78 |
|
|
2 |
Other items, net |
|
(39) |
|
|
(44) |
Changes in current assets and liabilities: |
|
|
|
||
Trade receivables |
|
(83) |
|
|
(16) |
Inventories |
|
(392) |
|
|
(277) |
Accounts payable |
|
48 |
|
|
(221) |
Other current assets |
|
(129) |
|
|
139 |
Other current liabilities |
|
(79) |
|
|
(477) |
Net cash provided by/(used for) operating activities |
|
2,796 |
|
|
2,620 |
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
||
Capital expenditures |
|
(777) |
|
|
(779) |
Proceeds from sale of business, net of cash disposed and working capital adjustments |
|
5 |
|
|
— |
Payments to acquire intangible assets |
|
(140) |
|
|
— |
Other investing activities, net |
|
63 |
|
|
41 |
Net cash provided by/(used for) investing activities |
|
(849) |
|
|
(738) |
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
||
Repayments of long-term debt |
|
(607) |
|
|
(823) |
Proceeds from issuance of long-term debt |
|
594 |
|
|
657 |
Dividends paid |
|
(1,452) |
|
|
(1,474) |
Repurchases of common stock |
|
(538) |
|
|
(150) |
Other financing activities, net |
|
(43) |
|
|
(26) |
Net cash provided by/(used for) financing activities |
|
(2,046) |
|
|
(1,816) |
Effect of exchange rate changes on cash, cash equivalents, and restricted cash |
|
(17) |
|
|
(53) |
Cash, cash equivalents, and restricted cash |
|
|
|
||
Net increase/(decrease) |
|
(116) |
|
|
13 |
Balance at beginning of period |
|
1,404 |
|
|
1,041 |
Balance at end of period |
$ |
1,288 |
|
$ |
1,054 |
|
|
||||
Schedule 16 |
|||||
Reconciliation of Net Cash Provided By/(Used For) Operating Activities to Free Cash Flow (in millions) (Unaudited) |
|||||
|
For the Nine Months Ended |
||||
|
|
|
|
||
Net cash provided by/(used for) operating activities |
$ |
2,796 |
|
$ |
2,620 |
Capital expenditures |
|
(777) |
|
|
(779) |
Free Cash Flow |
$ |
2,019 |
|
$ |
1,841 |
|
|
|
|
||
Adjusted Net Income/(Loss) |
$ |
2,703 |
|
$ |
2,711 |
Free Cash Flow Conversion |
|
75% |
|
|
68% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20241030085196/en/
Alex.Abraham@kraftheinz.com
anne-marie.megela@kraftheinz.com
Source: